Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
 
Register | Sign in
Home Page>Products
  Product News
QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

Vanquish UHPLC sees Thermo Fisher Scientific Reimagine UHPLC
Tuesday, July 15, 2014
Thermo Fisher Scientific has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

High Throughput Screening of Novel Protein Therapeutics
Tuesday, July 15, 2014
INTEGRA VIAFLO 96 - a handheld 96-channel electronic pipette.

High Specification Ultra Safe Pressure Reactor
Tuesday, July 15, 2014
PressureSyn - New, 125ml working volume high pressure reactor from Asynt.

Compact Sample Concentrator for R&D Departments
Tuesday, July 15, 2014
MiniVap™ blowdown sample concentrator from Porvair Sciences.

Automated Sample Preparation for the Analysis of Dioxins and PCBs
Tuesday, July 15, 2014
Dioxin system DEXTech™ to be presented by LCTech at Dioxin 2014 in Madrid.

Bio-Rad Introduces SsoAdvanced™ Universal Inhibitor-Tolerant SYBR®Green Supermix
Tuesday, July 15, 2014
New reagent delivers quality qPCR data from samples that are challenging to amplify.

SciGene Introduces High Capacity Oven
Tuesday, July 15, 2014
CytoBrite Slide Oven for performing extended FISH probe hybridizations.

Spinsolve Phosphorus from Magritek
Tuesday, July 15, 2014
The world’s first Phosphorus-31 capable benchtop NMR spectroscopy system.

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 10437
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv